The global blood glucose monitoring market size was US$ 13.95 billion in 2021. The global blood glucose monitoring market is forecast to grow to US$ 27.01 billion by 2030 by registering a compound annual growth rate (CAGR) of 8.1% during the forecast period from 2022 to 2030.

Factors Influencing the Market

Blood glucose monitoring systems are widely adopted by healthcare providers to offer effective diabetic management. In addition, they are cost-efficient, which makes them convenient for home use. As a result, the global blood glucose market will grow at a substantial growth rate.

The global blood glucose market is forecast to benefit from ongoing technological innovations. For instance, Roche introduced its new Accu-Chek Instant system in Feb 2021. This new "connected" blood glucose monitoring (BGM) system supports integrated Personalised Diabetes Management (iPDM). Thus, more such advancements in the blood glucose monitoring industry will contribute to the growth of the market.

The growing cases of diabetes will drive the blood glucose monitoring market forward. According to the report by International Diabetes Federation (IDF), around 450 million adults were diagnosed with diabetes in 2020. Thus, the high prevalence of this disease will contribute to the growth of the market.

Rising awareness related to the health hazards of diabetes and necessary measures to prevent the disease will fuel the growth of the global blood glucose monitoring market.

The trending use of smart monitoring apps will also offer ample growth opportunities for the blood glucose monitoring market.

COVID-19 Impact Analysis

The wake of the COVID-19 raised the demand for home healthcare, thereby boosting the growth of the global blood glucose monitoring market. In addition, diabetic patients were at a high risk of acquiring the virus. As a result, the need for proper care and regular diagnosis increased significantly. The growing inclination towards home health monitoring offered favorable opportunities for market growth. Companies operating in the healthcare devices segment witnessed soaring revenue. In addition, the rising number of FDA approvals further contributed to the growth of the global blood glucose monitoring market.

Regional Analysis

North America is forecast to dominate the global blood glucose monitoring market, followed by Asia-Pacific. The growth of the market is attributed to the presence of large pool of diabetic patients. In addition, high healthcare expenditure and rising awareness among the citizens related to early diagnosis will contribute to the market expansion.

Competitors in the Market

Abbott Laboratories
ARKRAY, Inc.
Bayer AG
Dexcom, Inc.
Lifescan Inc.
Ascensia Diabetes Care Holdings AG
B. Braun Melsungen AG
Terumo Medical Corporation
Medtronic plc
Nipro Diagnostics, Inc.
F. Hoffmann-La Roche Ltd
NU Skin Enterprises
NBTY Inc.
Herbalife International
Bionava Lifesciences
Other Prominent Players
Market Segmentation

The global blood glucose monitoring market segmentation focuses on Type, Device, End-User, and Region.

Based on Type

Invasive
Non-invasive
Based on Device

Continuous blood glucose monitoring system
Self-monitoring blood glucose monitoring system
Based on End-User

Hospitals
Diagnostic Center
Clinics
Others
Based on Region

North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Brazil
Argentina
Rest of South America